>> Signaling Pathways >> Others >> Menin-MLL

Menin-MLL

Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.

Products for  Menin-MLL

  1. Cat.No. 상품명 정보
  2. GC11837 MI-136 MI-136은 IC50이 31nM이고 Kd가 23.6nM인 메닌-MLL 단백질-단백질 상호작용(PPI)의 억제제입니다. MI-136은 AR 신호 전달을 차단하는 것으로 나타났으며 거세 저항성 종양에 대한 연구 가능성이 있습니다. MI-136  Chemical Structure
  3. GC11418 MI-2

    Menin-MLL inhibitor 2;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-

    An inhibitor of menin-MLL fusion protein interactions MI-2  Chemical Structure
  4. GC10388 MI-2 (hydrochloride) menin-MLL interaction inhibitor MI-2 (hydrochloride)  Chemical Structure
  5. GC12199 MI-3

    Menin-MLL inhibitor 3;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-

    An inhibitor of menin-MLL fusion protein interactions MI-3  Chemical Structure
  6. GC12173 MI-nc (hydrochloride) weak inhibitor of menin-MLL interaction MI-nc (hydrochloride)  Chemical Structure

5 Item(s)

페이지 당

내림차순